Unknown

Dataset Information

0

Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins.


ABSTRACT: BACKGROUND: Cancer cells frequently adopt cellular and molecular alterations and acquire resistance to cytostatic drugs. Chemotherapy with oxaliplatin is among the leading treatments for colorectal cancer with a response rate of 50%, inducing intrastrand cross-links on the DNA. Despite of this drug's efficiency, resistance develops in nearly all metastatic patients. Chemoresistance being of crucial importance for the drug's clinical efficiency this study aimed to contribute to the identification and description of some cellular and molecular alterations induced by prolonged oxaliplatin therapy. Resistance to oxaliplatin was induced in Colo320 (Colo320R) and HT-29 (HT-29R) colorectal adenocarcinoma cell lines by exposing the cells to increasing concentrations of the drug. Alterations in morphology, cytotoxicity, DNA cross-links formation and gene expression profiles were assessed in the parental and resistant variants with microscopy, MTT, alkaline comet and pangenomic microarray assays, respectively. RESULTS: Morphology analysis revealed epithelial-to-mesenchymal transition in the resistant vs parental cells suggesting alterations of the cells' adhesion complexes, through which they acquire increased invasiveness and adherence. Cytotoxicity measurements demonstrated resistance to oxaliplatin in both cell lines; Colo320 being more sensitive than HT-29 to this drug (P?

SUBMITTER: Virag P 

PROVIDER: S-EPMC3776436 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins.

Virag Piroska P   Fischer-Fodor Eva E   Perde-Schrepler Maria M   Brie Ioana I   Tatomir Corina C   Balacescu Loredana L   Berindan-Neagoe Ioana I   Victor Bogdan B   Balacescu Ovidiu O  

BMC genomics 20130716


<h4>Background</h4>Cancer cells frequently adopt cellular and molecular alterations and acquire resistance to cytostatic drugs. Chemotherapy with oxaliplatin is among the leading treatments for colorectal cancer with a response rate of 50%, inducing intrastrand cross-links on the DNA. Despite of this drug's efficiency, resistance develops in nearly all metastatic patients. Chemoresistance being of crucial importance for the drug's clinical efficiency this study aimed to contribute to the identif  ...[more]

Similar Datasets

| S-EPMC4128987 | biostudies-literature
2013-11-26 | GSE44446 | GEO
| S-EPMC10009566 | biostudies-literature
2013-11-26 | E-GEOD-44446 | biostudies-arrayexpress
| S-EPMC8140095 | biostudies-literature
| S-EPMC6696456 | biostudies-literature
| S-EPMC6224565 | biostudies-literature
| S-EPMC4425499 | biostudies-literature
| S-EPMC4124530 | biostudies-literature
| S-EPMC9913810 | biostudies-literature